Cell Genesys, Inc. (NASDAQ:CEGE.DL)
CAPS Rating:
A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked CEGE.DL yet. Tell us why you think CEGE.DL will outperform or underperform the market.
RSS Headlines
Fool UK
